EPCAM and ovarian cancer: Clinical and preclinical evaluations engaging CAR‐T‐cells directing EpCAM have been conducted126, 127 and revealed remarkable efficiency in targeting and elimination of EpCAM‐expressing cells in an ovarian cancer cell line (SKOV3)128 and xenografts.129